QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research).

QIAGEN takes part in several consortiums and EU grant projects such as SPIDIA4P (coordinator), Cancer-ID (participant), CBmed (participant), EASI-Genomics (participant), EU-STANDS4PM (participant) and is a member of various organisations including EDMA, MedTech Europe and the Personalized Medicine Coalition.

  • Qiagen Strasse 1, HILDEN 40724, Germany